These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3148094)

  • 1. Production and purification of anthrax toxin.
    Leppla SH
    Methods Enzymol; 1988; 165():103-16. PubMed ID: 3148094
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characterization of adenylyl cyclase from Bacillus anthracis.
    Leppla SH
    Methods Enzymol; 1991; 195():153-68. PubMed ID: 1903483
    [No Abstract]   [Full Text] [Related]  

  • 3. [The isolation and purification of the protective antigen and the edema factor from the culture filtrate of Bacillus anthracis STI-1].
    Rogov SN; Beznosov MV; Chugaĭ VL; Bashkova VA
    Med Parazitol (Mosk); 1995; (4):35-8. PubMed ID: 8587516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.
    Masure HR; Shattuck RL; Storm DR
    Microbiol Rev; 1987 Mar; 51(1):60-5. PubMed ID: 2882409
    [No Abstract]   [Full Text] [Related]  

  • 5. Shiga toxin: production and purification.
    Keusch GT; Donohue-Rolfe A; Jacewicz M; Kane AV
    Methods Enzymol; 1988; 165():152-62, 399-401. PubMed ID: 3231098
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel in vitro functional assays for the determination of anthrax toxin components.
    Hallis B; Silman NJ; Noonan S; Baker R; Roberts AD; Quinn CP; Marks T; Wiblin C; Lloyd G; Robinson A; Hudson MJ
    Dev Biol (Basel); 2002; 111():321-6. PubMed ID: 12678256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elaboration of Bacillus anthracis antigens in a new, defined culture medium.
    Ristroph JD; Ivins BE
    Infect Immun; 1983 Jan; 39(1):483-6. PubMed ID: 6401697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of gel chromatography for the isolation of biologically active toxin complex from Bacillus anthrax].
    Tafel'shteĭn EE; Markov EIu; Blinova LS; Kondrat'eva AM; Bashkova VA
    Mol Gen Mikrobiol Virusol; 1985 Dec; (12):39-42. PubMed ID: 3939572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis.
    Vetter SM; Schlievert PM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1302-5. PubMed ID: 15793101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine.
    Charlton S; Herbert M; McGlashan J; King A; Jones P; West K; Roberts A; Silman N; Marks T; Hudson M; Hallis B
    J Appl Microbiol; 2007 Nov; 103(5):1453-60. PubMed ID: 17953556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anthrax toxin on the chemiluminescence of human leukocytes].
    Tafel'shteĭn EE; Kalmakov SV; Chernov AB; Kondrat'eva AM; Bashkova VA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1988; (11):16-20. PubMed ID: 3146991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of microwells to investigate the effect of quorum sensing on growth and antigen production in Bacillus anthracis Sterne 34F2.
    Mukhopadhyay TK; Allison N; Charlton S; Ward J; Lye GJ
    J Appl Microbiol; 2011 Nov; 111(5):1224-34. PubMed ID: 21895896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis.
    Ramirez DM; Leppla SH; Schneerson R; Shiloach J
    J Ind Microbiol Biotechnol; 2002 Apr; 28(4):232-8. PubMed ID: 11986925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant expression and purification of a tumor-targeted toxin in Bacillus anthracis.
    Bachran C; Abdelazim S; Fattah RJ; Liu S; Leppla SH
    Biochem Biophys Res Commun; 2013 Jan; 430(1):150-5. PubMed ID: 23200832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of soluble form of adenylyl cyclase from testes.
    Braun T
    Methods Enzymol; 1991; 195():130-6. PubMed ID: 1851925
    [No Abstract]   [Full Text] [Related]  

  • 16. Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice.
    Glomski IJ; Corre JP; Mock M; Goossens PL
    Infect Immun; 2007 Oct; 75(10):4754-61. PubMed ID: 17635863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalable purification of Bacillus anthracis protective antigen from Escherichia coli.
    Gwinn W; Zhang M; Mon S; Sampey D; Zukauskas D; Kassebaum C; Zmuda JF; Tsai A; Laird MW
    Protein Expr Purif; 2006 Jan; 45(1):30-6. PubMed ID: 15935696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.
    Kumar P; Ahuja N; Bhatnagar R
    Infect Immun; 2001 Oct; 69(10):6532-6. PubMed ID: 11553601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full biological activity in E. coli.
    Liu J; Cai C; Guo Q; Zhang J; Dong D; Li G; Fu L; Xu J; Chen W
    Protein Expr Purif; 2013 May; 89(1):56-61. PubMed ID: 23459291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
    Cote CK; Welkos SL
    Toxins (Basel); 2015 Aug; 7(8):3167-78. PubMed ID: 26287244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.